Serum adiponectin enhances insulin sensitivity, and individuals with obesity, type 2 diabetes mellitus (DM), and other metabolic disorders have low serum adiponectin levels [19]. This evidence concerns the gene ADIPOQ and type 2 diabetes mellitus.